IAVI utilizes its expertise and technologies to address unmet global health needs and develop vaccines and antibody products that are accessible to everyone around the world. IAVI is able to do this with the support of various foundations, governmental and non-governmental organizations.
To advance the development of HIV vaccines IAVI conducts translational research programs worldwide and more specifically in partnership with Clinical Research Centers in Eastern and Southern Africa. This research leads to the accumulation of clinical and laboratory data derived from clinical and epidemiology studies, and the collection and analysis of human donor samples. High demand for study data and associated samples led IAVI, its research partners and collaborators, to create and implement a digital repository to collect, assemble, and manage this data which is used to support ongoing and future research.